HHealth Read More Novo Nordisk’s Wegovy® cuts risk of heart attack, stroke orAugust 31, 2025 Compared with tirzepatide, Wegovy® (semaglutide 2.4 mg) showed a significant 57% greater reduction in the risk of heart…